Press releases
Ken Paulus of Prime Therapeutics becomes chairman of PCMA Board of Directors
Paulus honored to take on this role within our industry at this important time
September 15, 2020“I’m honored to take on this role within our industry at this important time,” said Mr. Paulus. “As we continue to deal with a crippling global pandemic, prescription drug access and affordability are central issues. We need to remain committed to putting patients first as we move forward.”
PCMA is the national association representing America’s pharmacy benefit managers (PBMs) which administer prescription drug plans for more than 266 million Americans with health coverage through Fortune 500 companies, health insurers, labor unions, Medicare, Medicaid, and the Federal Employees Health Benefits Program, as well as the Exchanges established by the Affordable Care Act.
“I’d like to thank Alan Lotvin for his leadership and dedication as PCMA’s chairman. He has navigated the association and the industry through a difficult time for our nation. I congratulate Ken on his new role,” said PCMA President & CEO JC Scott. “Our industry will benefit greatly from the diverse experience and expertise that he brings as the next chairman of PCMA.”
Related news
Press releases
July 10, 2024
Prime continues to lead industry on GLP-1 research: 1 in 7 stays on GLP-1 drugs for weight loss after two years
Real-world, integrated data follows-up on previous insights, analytics.
Press releases
July 8, 2024
Prime Therapeutics hires new CIO to lead digital transformation
Dinesh Kandanchatha joined the organization July 1.
Press releases
June 19, 2024
Prime/MRx’s new Pharmacy Match technology-driven solution expands specialty pharmacy access and choice
Using real-time pricing, Pharmacy Match drives affordability for plan sponsors while offering access to the most competitive pharmacy for each member.